Prospect Capital (NASDAQ:PSEC) reported quarterly earnings of $0.19 per share which beat the analyst consensus estimate of $0.17 by 11.76 percent. This is unchanged from the same period last year.
From Cannabis MSO To Drug Development: Goodness Growth Wants To Understand Traditional Psychedelics Use
Resurgent Biosciences, a subsidiary of Goodness Growth Holdings, Inc. (CSE: GDNS) (OTCQX: GDNSF), is launching a survey study that will look into the varying effects of entheogen and psychedelic experiences for therapeutic, religious and spiritual purposes.
